Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic Surgery
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to test the hypothesis that surgical site infiltration with
liposomal bupivacaine (LB) is non-inferior to and more cost effective than thoracic epidural
analgesia (TEA) for patients undergoing open gynecologic surgery on an established enhanced
recovery program (ERP) using a non-inferiority randomized trial design. The impact of TEA and
surgical site infiltration with LB on neuroendocrine and inflammatory mediators of surgical
stress response (SSR) will also be investigated as a translational endpoint.
Phase:
Phase 3
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins